Johnson & Johnson (NYSE: JNJ) is a healthcare conglomerate with a market capitalisation exceeding $549 billion, operating across pharmaceuticals and medical devices following its consumer health spin-off. For Muslim investors asking “is Johnson & Johnson ethical-trading/” style=”color:#D8AF44;text-decoration:underline” title=”Ethical Trading”>halal?”, the answer is not straightforward. The business itself is largely permissible, but the financial structure presents a compliance challenge.
What We Screen For
Shariah-compliant equity screening examines three core financial ratios:
- Debt Purity — Measures interest-bearing debt relative to market capitalisation. Higher scores indicate lower debt dependency.
- Liquidity Purity — Assesses whether a company’s assets are predominantly productive. Scores above 50% are preferred.
- Revenue Purity — Evaluates what share of revenue derives from permissible activities. Scores above 67% indicate compliance.
The Numbers
| Screening Ratio | JNJ Score | Threshold | Status |
|---|---|---|---|
| Debt Purity | 27.09% | >50% | ✗ Fail |
| Liquidity Purity | 99.40% | >50% | ✓ Pass |
| Revenue Purity | 77.58% | >67% | ✓ Pass |
| Overall Ethical Score | 63.21% | — | Bronze Tier |
Detailed Assessment
Johnson & Johnson’s compliance picture is a tale of one failing ratio against two passing ones.
The debt purity score of 27.09% is the clear obstacle. JNJ carries substantial long-term debt, historically exceeding $25 billion, used to fund acquisitions (including the Kenvue spin-off), research and development, and capital investments. This places the interest-bearing debt ratio firmly below the 50% compliance threshold.
The liquidity purity is excellent at 99.40%. JNJ’s assets are almost entirely productive — manufacturing facilities, research labs, intellectual property, and pharmaceutical inventories. The company’s asset base is strongly rooted in real economic activity.
The revenue purity at 77.58% passes the 67% threshold. JNJ’s revenue comes predominantly from pharmaceuticals and medical devices — both permissible sectors under Shariah law. Healthcare is widely considered a beneficial and encouraged industry. The slight discount from 100% may reflect minor income from interest on cash holdings or non-core financial activities.
At 63.21% overall ethical score and Bronze Tier, JNJ sits in a zone where scholars may differ. Investors with a strict interpretation would avoid it due to the debt ratio; those applying a more lenient standard might consider it acceptable given the strong business fundamentals.
Shariah-Compliant Alternatives in Healthcare
If JNJ’s debt level is a concern, investors may consider healthcare-adjacent companies with cleaner balance sheets:
- ExxonMobil (XOM) — Bronze Tier, 87.85% ethical score. Different sector but passes all three screens with strong margins.
- Costco (COST) — Watch Tier, 84.40% ethical score. Consumer staples with a 67.88% debt purity.
Explore the full list on our Ethical Trading Screener.
Further Research
View the full Johnson & Johnson profile on our JNJ Ticker Page.
Explore Shariah-screened equities on our Ethical Trading Screener.
Deepen Your Understanding
Related articles from the Titan Protect Foundry:
